Search Results

Showing 21 – 40 of 57 results

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

by CTG

in Influenza, Human

Other

Alabama

Deadline:

12/01/2026

Flu Vaccine Responses in the Setting of Melanoma Treatment

by CTG

in Viral Vaccines

Other

Pennsylvania

Deadline:

07/01/2026

Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement

by CTG

in COVID-19

Other

California

Deadline:

06/30/2027

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

by CTG

in Colorectal Neoplasms

Other

Arizona

Deadline:

03/01/2027

Association Between Gut Microbiome and Dietary Determinants and Vaccine Response

by CTG

in Influenza

Other

Texas

Deadline:

02/28/2027

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

by CTG

in Influenza Prevention, Pandemic Influenza Prevention

Other

Maryland

Deadline:

08/18/2027

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

by CTG

in Acute Lymphoblastic Leukemia

Other

California

Deadline:

03/07/2029

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

by CTG

in COVID-19, COVID-19 Pneumonia, COVID-19 Respiratory Infection, COVID-19 Acute Respiratory Distress Syndrome, SARS-CoV-2 Virus

Other

Texas

Deadline:

03/30/2026

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

by CTG

in HIV Infections, Age

Other

Minnesota

Deadline:

06/30/2029

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

by CTG

in Seasonal Influenza, Influenza Prevention

Other

Maryland

Deadline:

07/31/2026

iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma

by CTG

in Neuroblastoma, Osteosarcoma

Other

Texas

Deadline:

10/31/2034

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

by CTG

in Influenza, COVID -19, COVID - 19, COVID 19, Respiratory Virus

Other

Maryland

Deadline:

09/01/2027

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

by CTG

in Influenza, Human

Other

Pennsylvania

Deadline:

03/31/2028

Immunology of Ebola Vaccine

by CTG

in Ebola Virus Disease

Other

Georgia

Deadline:

08/31/2026

Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement

by CTG

in Cardiovascular Diseases, Influenza, Behavior, Social

Other

California

Deadline:

03/31/2026

Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

by CTG

in COVID-19, Vaccine Hesitancy

Other

Kentucky

Deadline:

09/01/2027

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

by CTG

in Influenza

Other

Iowa

Deadline:

05/26/2026

Systems Investigation of Vaccine Responses in Aging and Frailty

by CTG

in Influenza

Other

Connecticut

Deadline:

04/01/2027

BRCA1/2 Flu Vaccine

by CTG

in BRCA1 Mutation, BRCA2 Mutation

Other

Pennsylvania

Deadline:

06/01/2026

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

by CTG

in Gonorrhea Male

Other

North Carolina

Deadline:

02/01/2028

Load more All clinical trials loaded.

Your Selected

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Flu Vaccine Responses in the Setting of Melanoma Treatment

Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Association Between Gut Microbiome and Dietary Determinants and Vaccine Response

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

Immunology of Ebola Vaccine

Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

Systems Investigation of Vaccine Responses in Aging and Frailty

BRCA1/2 Flu Vaccine

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps